Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Schering-Plough isolates potential lead for new schizophrenia drugs from Chinese plant

June 24, 1997

Lilly licenses Prozac patent rights from Interneuron for PMS treatment

June 24, 1997

MS&D describes potent and selective 5-HT1Dalpha receptor agonists

June 24, 1997

Agents for depression and related disorders from American Home Products

June 24, 1997

Melatonin reduces the effects of nifedipine in hypertensive patients

June 23, 1997

Gabitril introduced in Germany

June 23, 1997

IND filed for new anxiolytic compound, NGD-91-2

June 23, 1997

Monoamine reuptake inhibitors disclosed by NeuroSearch

June 23, 1997

Hi-Tech Pharmacal obtains license to huperzine

June 20, 1997

Preclinical results reported by Lilly and Synaptic for potent and selective 5-HT1F agonist

June 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...